MDWD
MDWD
NASDAQ · Pharmaceuticals

Mediwound Ltd

$17.13
+0.52 (+3.13%)
As of Mar 25, 3:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
26.03M
Net Income
-38,903,480
Gross Margin
13.0%
Profit Margin
-149.5%
Rev Growth
-5.2%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 13.0% 13.0% 36.4% 36.4%
Operating Margin -95.9% -86.3% 13.9% 16.0%
Profit Margin -149.5% -142.0% 15.0% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 26.03M 27.47M 84.88M 71.76M
Gross Profit 3.39M 3.58M 30.88M 26.11M
Operating Income -24,972,861 -23,715,917 11.80M 11.51M
Net Income -38,903,480 -36,945,375 12.73M 10.88M
Gross Margin 13.0% 13.0% 36.4% 36.4%
Operating Margin -95.9% -86.3% 13.9% 16.0%
Profit Margin -149.5% -142.0% 15.0% 15.2%
Rev Growth -5.2% -5.2% +19.4% +16.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 19.68M 19.68M 126.77M 98.08M
Total Equity 88.46M 88.46M 68.95M 72.24M
D/E Ratio 0.22 0.22 1.84 1.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -39,657,294 -39,753,539 16.15M 13.06M
Free Cash Flow 13.25M 12.55M